Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Med

Topics

Biology

Quantum Mechanics

Physics

Chemistry

Medicine

Show all topics

DOI

10.1016/j.medj.2024.06.007

License

CC-BY-NC